skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Inhibitory effects of amiloride on alpha adrenoceptors in canine vascular smooth muscle

Journal Article · · Journal of Pharmacology and Experimental Therapeutics; (USA)
OSTI ID:6727750
; ; ;  [1]
  1. McMaster Univ., Hamilton, Ontario (Canada)

Amiloride inhibits vascular smooth muscle contractions from canine aorta and saphenous vein. The mechanisms were studied using radioligand binding and functional techniques. Amiloride inhibited ({sup 3}H)prazosin and ({sup 3}H)rauwolscine binding to alpha-1 and alpha-2 adrenoceptors in a concentration-dependent manner. Amiloride increased Kd values for ({sup 3}H)rauwolscine without affecting the maximum binding of ({sup 3}H)prazosin. These results suggest that the drug interacts with the alpha-1 adrenoceptor binding sites in a competitive manner and with the alpha-2 adrenoceptor binding sites in a noncompetitive manner. Amiloride reduced maximal contractile responses to agonists selective for both alpha adrenoceptors and to elevated K+, the EC50 values were increased by about 10-fold in the presence of amiloride. In Ca+(+)-free Krebs' solution, contractions induced in saphenous vein after addition of Ca++ in saphenous vein in the presence of adrenoceptor agonists were inhibited by amiloride. Our results suggest that amiloride reduced alpha-1 and alpha-2 adrenoceptor-mediated responses and inhibited Ca++ influx.

OSTI ID:
6727750
Journal Information:
Journal of Pharmacology and Experimental Therapeutics; (USA), Vol. 253:2; ISSN 0022-3565
Country of Publication:
United States
Language:
English